MENU
+Compare
MRK
Stock ticker: NYSE
AS OF
Aug 25, 04:59 PM (EDT)
Price
$85.33
Change
-$2.04 (-2.33%)
Capitalization
213.09B

MRK Merck & Co Forecast, Technical & Fundamental Analysis

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections... Show more

MRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for MRK with price predictions
Aug 22, 2025

Aroon Indicator for MRK shows an upward move is likely

MRK's Aroon Indicator triggered a bullish signal on July 31, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 219 similar instances where the Aroon Indicator showed a similar pattern. In of the 219 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 13, 2025. You may want to consider a long position or call options on MRK as a result. In of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for MRK just turned positive on August 14, 2025. Looking at past instances where MRK's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

MRK moved above its 50-day moving average on August 13, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for MRK crossed bullishly above the 50-day moving average on August 15, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MRK advanced for three days, in of 325 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MRK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.350) is normal, around the industry mean (9.528). P/E Ratio (13.145) is within average values for comparable stocks, (24.119). Projected Growth (PEG Ratio) (0.838) is also within normal values, averaging (1.904). Dividend Yield (0.038) settles around the average of (0.027) among similar stocks. P/S Ratio (3.393) is also within normal values, averaging (3.460).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. MRK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MRK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
MRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

MRK is expected to report earnings to rise 11.27% to $2.37 per share on October 30

Merck & Co MRK Stock Earnings Reports
Q3'25
Est.
$2.37
Q2'25
Beat
by $0.10
Q1'25
Beat
by $0.08
Q4'24
Missed
by $0.09
Q3'24
Beat
by $0.07
The last earnings report on July 29 showed earnings per share of $2.13, beating the estimate of $2.03. With 9.20M shares outstanding, the current market capitalization sits at 213.09B.
A.I.Advisor
published Dividends

MRK paid dividends on July 08, 2025

Merck & Co MRK Stock Dividends
А dividend of $0.81 per share was paid with a record date of July 08, 2025, and an ex-dividend date of June 16, 2025. Read more...
A.I. Advisor
published General Information

General Information

a developer of human and animal health products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
126 East Lincoln Avenue
Phone
+1 908 740-4000
Employees
72000
Web
https://www.merck.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MYI10.540.02
+0.19%
Blackrock Muniyield Quality Fund III
PSCQ28.55-0.02
-0.08%
Pacer Swan SOS Conservative (Oct) ETF
FDTX38.74-0.07
-0.19%
Fidelity Disruptive Technology ETF
AVUV98.57-0.45
-0.45%
Avantis US Small Cap Value ETF
IPAV28.00-0.36
-1.29%
Global X Infrastructure Dev ex-U.S. ETF

MRK and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MRK has been loosely correlated with PFE. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if MRK jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRK
1D Price
Change %
MRK100%
-2.36%
PFE - MRK
57%
Loosely correlated
-2.86%
BIIB - MRK
49%
Loosely correlated
-2.12%
ABBV - MRK
48%
Loosely correlated
-1.45%
BMY - MRK
45%
Loosely correlated
-1.63%
NVS - MRK
45%
Loosely correlated
-1.53%
More